Hikma Pharmaceuticals (HIKl)

1,507.14 -16.00 (-1.05%)
Closed GBP Disclaimer

HIKl Earnings

Title
Quarterly
Annually
Latest Release Feb 24, 2022 Dec 31, 2021
EPS
-- 0.98
1.81
Revenue
-- 1,283M
2.55B
Next release Date Feb 23, 2023 -
Expected growth INF% -
Clear All
0Selected
Please try another search
EPS
Revenue
Historical Earnings
EPS
Revenue
Forecast
Release Date
Period End
EPS Actual
EPS Forecast
EPS Surprise
Revenue Actual
Revenue Forecast
Revenue Surprise
Feb 23, 2023 12/2022 -- 0.91 -0.91 -- 1,311M -1
Aug 04, 2022 06/2022 -- 0.95 -0.95 -- 1,215M -1
Feb 24, 2022 12/2021 -- 0.98 -0.98 -- 1,283M -1
Aug 06, 2021 06/2021 -- 0.90 -0.9 -- 1,212M -1
Feb 25, 2021 12/2020 -- -1.22 +1.22 -- 1,214M -1
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.